Stock listing

NASDAQ:BRVE Braveheart Bio, Inc. Stock

Home listing (NASDAQ) of Braveheart Bio, Inc.

Follow Braveheart Bio, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BRVE

$21.04 USD -0.47 (-2.2%)

Close on Nov 2, 2026

Past 3 months -29.4% · daily closes, Aug 6, 2026 – Nov 2, 2026, adjusted for splits
Day range
$20.51 – $21.79 USDNov 2, 2026
Volume
260,119 sharesNov 2, 2026
Market cap
$1.89B USDAt the close on Nov 2, 2026 · price × 90.04M shares outstanding
Traded on an average day
$11.90M USDMedian day 335,322 shares · last 3 months, Aug 6, 2026 – Nov 2, 2026

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BRVE · Home$21.04 USD-0.47 (-2.2%)260,119$21.79$21.79$20.51$21.51Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 2, 2026 · NASDAQ:BRVE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$21.04-0.47-2.2%$21.79$21.79$20.51260,119
$21.51+0.32+1.5%$21.29$21.77$20.75533,666
$21.19-0.57-2.6%$21.55$22.20$20.62304,125
$21.76-0.06-0.3%$21.74$21.85$20.77246,219
$21.82-0.05-0.2%$22.00$22.22$21.38156,109
$21.87+0.43+2.0%$21.71$21.96$21.32101,220
$21.44-0.04-0.2%$21.45$21.53$20.58119,555
$21.48+0.44+2.1%$21.14$21.80$20.68156,502
$21.04+0.77+3.8%$20.64$21.36$19.67224,146
$20.27+1.06+5.5%$19.21$20.81$19.15323,870
$19.21+0.50+2.7%$18.72$19.42$18.15333,743
$18.71-0.84-4.3%$19.50$19.59$18.00414,900
$19.55+0.21+1.1%$19.54$20.13$19.18206,100
$19.34+0.01+0.1%$19.33$19.90$18.62462,800
$19.33-1.03-5.1%$20.44$20.56$19.04212,300
$20.36+0.34+1.7%$20.17$20.78$19.22155,100
$20.02+0.93+4.9%$18.91$20.24$18.44255,000
$19.09+0.51+2.7%$18.53$19.32$17.86389,200
$18.58-1.21-6.1%$19.61$19.65$18.47336,900
$19.79-1.56-7.3%$21.59$21.59$19.67590,300
$21.35+0.08+0.4%$21.57$22.02$19.83889,000
$21.27-0.14-0.7%$21.44$21.98$20.77462,800
$21.41+1.21+6.0%$19.90$22.36$19.88669,400
$20.20-2.14-9.6%$22.30$22.30$20.01967,500
$22.34+1.27+6.0%$21.00$22.51$20.37719,200
$21.07+0.45+2.2%$20.25$22.05$20.01389,300
$20.62-2.75-11.8%$23.58$23.86$20.53471,800
$23.37+1.91+8.9%$21.41$23.80$20.70396,700
$21.46-2.15-9.1%$23.21$23.77$21.31521,700
$23.61-1.41-5.6%$25.41$25.41$23.42829,400
$25.02-4.18-14.3%$28.90$28.90$24.631,570,800
$29.20+1.49+5.4%$27.78$29.50$27.472,017,800
$27.71+0.26+0.9%$27.76$28.90$27.16577,400
$27.45+0.74+2.8%$26.82$28.90$26.22550,700
$26.71-0.31-1.1%$26.95$27.98$26.31275,000
$27.02+0.38+1.4%$26.75$27.76$26.29209,200
$26.64-0.61-2.2%$28.12$28.74$26.54283,600
$27.25-1.66-5.7%$28.94$29.50$26.47286,000
$28.91-0.50-1.7%$29.13$29.97$27.93309,700
$29.41+2.67+10.0%$27.18$29.91$27.18613,200
$26.74+0.47+1.8%$25.81$27.48$25.39272,100
$26.27-0.68-2.5%$27.22$27.22$25.19327,600
$26.95+0.67+2.5%$26.53$27.78$25.69394,500
$26.28+0.78+3.1%$25.76$27.06$24.90342,900
$25.50-1.94-7.1%$27.95$27.95$24.31806,200
$27.44-0.42-1.5%$27.98$29.24$27.38162,500
$27.86+0.10+0.4%$27.50$29.00$27.50127,800
$27.76+0.12+0.4%$27.80$28.65$27.01215,200
$27.64+0.14+0.5%$28.29$29.25$27.07155,335
$27.50-0.08-0.3%$27.64$28.00$26.17101,993
$27.58+0.16+0.6%$27.49$28.10$27.12130,500
$27.42-1.55-5.4%$28.43$28.89$26.54176,200
$28.97+2.22+8.3%$26.99$30.12$26.86391,800
$26.75-0.91-3.3%$27.64$28.50$25.76215,000
$27.66+0.63+2.3%$26.97$28.29$26.67310,200
$27.03+1.06+4.1%$25.92$27.15$25.01330,000
$25.97-0.18-0.7%$26.10$26.64$24.88707,600
$26.15+1.14+4.6%$24.90$26.67$24.90634,000
$25.01-2.52-9.2%$27.53$27.88$24.61724,700
$27.53-2.47-8.2%$30.78$32.00$27.45415,700
$30.00+0.20+0.7%$29.70$32.00$28.47566,600
$29.80——$30.20$31.56$29.423,292,200
Ticker
NASDAQ:BRVE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Braveheart Bio, Inc. news

Financings

  • Public offering of common stock

    Sep 8, 2026

    Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4

    Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead)

    Announced Aug 6, 2026 · Closed Aug 7, 2026 · Closed Sep 8, 2026

Read by 6ix AI from the company's releases

Decks

Braveheart Bio, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
7 in the last 12 months · 7 in all · newest Oct 30, 2026 · oldest 2026
Decks
2 decks · latest May 11, 2026

Where Braveheart Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BRVE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BRVEBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Braveheart Bio, Inc.